EPITOPE SUMMARY | |
---|---|
NLVPMVATV is a linear peptidic epitope (epitope ID ) studied as part of 65 kDa phosphoprotein (UniProt:P06725) from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assays, MHC ligand assays and has 3D structure(s) , , , , and . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
HLA-A2 | / |
HLA-A*02:03 | / |
HLA-A*02:06 | / |
HLA-A*02:11 | / |
HLA-A*02:12 | / |
HLA-A*02:16 | / |
HLA-A*02:19 | / |
HLA-A*34:02 | / |
HLA-A*69:01 | / |
HLA-A*03:01 | / |
HLA-A*24:02 | / |
HLA-B*07:02 | / |
B Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
dissociation constant KD | / |
off rate | / |
on rate | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
IFNg release | / |
cytotoxicity | / |
TNFa release | / |
proliferation | / |
IL-2 release | / |
degranulation | / |
granzyme B release | / |
activation | / |
dissociation constant KD | / |
CCL4/MIP-1b release | / |
perforin release | / |
3D structure | / |
tumor burden after challenge after adoptive transfer | / |
pathogen burden after challenge after adoptive transfer | / |
survival after pathogen challenge after adoptive transfer | / |
T cell- APC binding | / |
decreased disease after adoptive transfer | / |
GM-CSF release | / |
IL-4 release | / |
TNF release | / |
IL-5 release | / |
binding constant | / |
CXCL9/MIG release | / |
granzyme A release | / |
IL-1b release | / |
IL-6 release | / |
survival after tumor challenge after adoptive transfer | / |
IL-10 release | / |
IL-13 release | / |
type IV hypersensitivity (DTH) | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |